Literature DB >> 7794242

Amyloid P component promotes aggregation of Alzheimer's beta-amyloid peptide.

H Hamazaki1.   

Abstract

Amyloid P component (AP) has been recognized as a beta-amyloid-associated protein but the pathological role is not known. In the present experiments, it has been shown that AP promotes the aggregation of Alzheimer's beta-amyloid peptide (A beta) in the presence of a physiological concentration of Ca2+. The aggregation promotion was observed at a concentration of soluble A beta 1-40 in human cerebrospinal fluid. The results suggest that AP is possibly a pathogenic factor of the cerebral amyloidosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7794242     DOI: 10.1006/bbrc.1995.1819

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component.

Authors:  Simon E Kolstoe; Basil H Ridha; Vittorio Bellotti; Nan Wang; Carol V Robinson; Sebastian J Crutch; Geoffrey Keir; Riitta Kukkastenvehmas; J Ruth Gallimore; Winston L Hutchinson; Philip N Hawkins; Stephen P Wood; Martin N Rossor; Mark B Pepys
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-16       Impact factor: 11.205

Review 2.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

3.  The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysis.

Authors:  C Soto; E M Castaño
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

4.  Investigating interactions of the pentraxins serum amyloid P component and C-reactive protein by mass spectrometry.

Authors:  J Andrew Aquilina; Carol V Robinson
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

5.  The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration.

Authors:  Lincoln V Johnson; William P Leitner; Alexander J Rivest; Michelle K Staples; Monte J Radeke; Don H Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-20       Impact factor: 11.205

6.  Interactions between amyloid-β and hemoglobin: implications for amyloid plaque formation in Alzheimer's disease.

Authors:  Jia-Ying Chuang; Chu-Wan Lee; Yao-Hsiang Shih; Tingting Yang; Lung Yu; Yu-Min Kuo
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

Review 7.  Therapeutic Uses of Bacterial Subunit Toxins.

Authors:  Clifford Lingwood
Journal:  Toxins (Basel)       Date:  2021-05-26       Impact factor: 4.546

8.  Inhibition of TTR aggregation-induced cell death--a new role for serum amyloid P component.

Authors:  Karin Andersson; Malgorzata Pokrzywa; Ingrid Dacklin; Erik Lundgren
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

9.  Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo.

Authors:  Raya Al-Shawi; Glenys A Tennent; David J Millar; Angela Richard-Londt; Sebastian Brandner; David J Werring; J Paul Simons; Mark B Pepys
Journal:  Open Biol       Date:  2016-02       Impact factor: 6.411

Review 10.  The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs.

Authors:  Mark B Pepys
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.